Produção e purificação de biogás utilizando microalga spirulina sp. LEB-18

O crescimento da população mundial e a tentativa de substituição parcial dos combustíveis fósseis por novas fontes de energia têm levado a uma maior atenção quanto à possível escassez de alimentos e a carência de grandes áreas disponíveis para agricultura. Microalgas, por meio do metabolismo fotossintético, utilizam energia solar e gás carbônico como nutrientes para o crescimento. A microalga Spirulina pode ser utilizada como suplemento alimentar, na biofixação de CO2, como fonte de biocombustíveis e no tratamento de efluentes. A digestão anaeróbia da biomassa microalgal produz biogás e os resíduos deste processo podem ser utilizados como substrato para novos cultivos da microalga. O objetivo deste trabalho foi estudar a conversão de Spirulina sp. LEB-18 em biogás em escala piloto e produzir biomassa microalgal utilizando os efluentes bicarbonato e dióxido de carbono do processo anaeróbio como fonte de nutrientes. Spirulina foi utilizada como substrato na digestão anaeróbia para produção de biogás em escala piloto sob temperaturas variáveis (12- 38 °C). Efluente do processo anaeróbio foi adicionado (20 %, v/v) como fonte de carbono no cultivo da microalga para avaliar o crescimento e a composição da biomassa. A seguir foi avaliada a capacidade da microalga de remover CO2 presente no biogás através de biofixação para obtenção do biocombustível purificado. O biogás produzido sob as diferentes temperaturas apresentou entre 72,2 e 74,4 % de CH4, quando realizado nas temperaturas 12 a 21 °C e 26 a 38 °C, respectivamente. A redução na temperatura do processo anaeróbio provocou um decréscimo na conversão de biomassa em biogás (0,30 para 0,22 g.g-1 ), ocorrendo dentro da faixa adequada e segura para as bactérias metanogênicas (pH 6,9; alcalinidade entre 1706,0 e 2248,0 mg.L-1 CaCO3 e nitrogênio amoniacal 479,3 a 661,7 mg.L-1 ). Os cultivos de Spirulina sp. LEB-18 em efluente anaeróbio contendo 20 % (v/v) e meio Zarrouk modificado (NaHCO3 2,8 e 5,3 g.L-1 ) apresentaram velocidade específica máxima de crescimento entre 0,324 e 0,354 d-1 , produtividade volumétrica entre 0,280 e 0,297 g.L-1 .d-1 e produtividade areal entre 14,00 e 14,85 g.m-2 .d-1 , sem diferenças significativas (p > 0,05) entre as diferentes condições estudadas. Lipídios variaram entre 4,9 e 5,0 % com proporção de ácido linoleico maximizada nos meios com efluente e ácido alfa-linolênico reduzida nesses meios em comparação ao meio Zarrouk completo. Nos ensaios para avaliar a capacidade da microalga Spirulina sp. LEB-18 de remover CO2 contaminante no biogás, as máximas concentrações celulares e produtividades de biomassa variaram, respectivamente, entre 1,12 e 1,24 g.L-1 e 0,11 e 0,14 g.L-1 .d-1 , não apresentando diferenças significativas (p > 0,05) entre os ensaios. A maior fixação diária total (FDT) de dióxido de carbono obtida foi 58,01 % (v/v) em cultivos com adição de biogás contendo 25 % (v/v) CO2. Obteve-se biogás com 89,5 % (v/v) de CH4 após injeção em cultivos de Spirulina, no qual aproximadamente 45 % (v/v) do CO2 injetado foi fixado pela microalga, gerando biomassa para diversas aplicações e biogás purificado.

Modelagem eletroquímica e do distúrbio ácido-básico em atletas de karatê participantes do campeonato mundial WKO 2014

The objective of this study was to analyze the electrochemical and acid-base disorders in high performance athletes during the World Karate Championship hosted by the WKO (World Karate Organization) in 2014. In this study 19 male athletes were analyzed (age 34 ± 8), black belts and with over 5 years of experience in the sport. Capillary blood samples from the digital pulp of the finger were collected in three stages: rest, 5 minutes after and 10 minutes after fighting (kumite). The sample was analyzed using blood gas analyzer GEM Premier 3000, using the parameters pH, Na+, K+, Ca2+, lactate e HCO3−. The values related to acid-base disturbance presented statistical differences (p <0.05) in most of the collected moments. The lactate levels found were 2.77 ± 0.97mmol / L in rest, 6.57 ± 2.1 for 5 minutes after and 4.06 ± 1.55 for 10 minutes after combat. The samples collected for the electrolytic markers showed no statistical differences in their values (p <0.05). Through the data collected, we conjecture that the sport can be characterized as a high-intensity exercise and with a predominance of the glycolytic system. The analysis of acid-base disturbance is an efficient method to assist in the control of training loads.

Usefulness of clinical observations and blood chemistry values for predicting clinical outcomes in dairy goats with pregnancy toxaemia

Background Pregnancy toxaemia (PT) is a disease that affects pregnant goats during their last month of gestation and is characterized by a high case fatality rate. This study involved 32 does maintained on a commercial dairy goat farm that were diagnosed with PT. A physical examination was performed on and haematology parameters obtained from each doe, at the time of diagnosis. The data from the 24 PT goats that died was compared with the corresponding data from the 8 PT goats that survived. Results Polypnea, swollen limbs, anorexia with absence of ruminal motility, recumbency, nervous signs and drooping ears were the most frequently observed clinical manifestations. Nineteen out of 21 recumbent goats died. Sixteen out of 17 goats with anorexia and absence of ruminal motility died. Mean beta-hydroxybutyric acid (BHBA) values in the goats that died were not significantly different from those in goats that survived. The blood values for pH and pCO2 (p < 0.005) as well as for HCO3 −, BE and K+ (p < 0.001) were significantly lower in the goats that died than in those that survived. Conclusions The clinical signs most indicative of a poor prognosis are anorexia with absence of ruminal motility and recumbency. Among the blood parameters to be considered, hypokalaemia and metabolic acidosis are the most relevant. Goats with PT have a high mortality and their condition can deteriorate very fast. Based on the authors’s experience, a good strategy to minimize the economic losses caused by PT is to focus on the offspring survival rate since an early decision (induction of kidding or caesarian surgery) can increase the number of alive kids.

Pathogenetic mechanisms of gastrointestinal symptoms in a mouse model of Fabry disease: insights on the microbiota-gut-brain axis

Fabry disease (FD), X-linked metabolic disorder caused by a deficiency in α-galactosidase A activity, leads to the accumulation of glycosphingolipids, mainly Gb3 and lyso-Gb3, in several organs. Gastrointestinal (GI) symptoms are among the earliest and most common, strongly impacting patients’ quality of life. However, the origin of these symptoms and the exact mechanisms of pathogenesis are still poorly understood, thus the pressing need to improve their knowledge. Here we aimed to evaluate whether a FD murine model (α-galactosidase A Knock-Out) captures the functional GI issues experienced by patients. In particular, the potential mechanisms involved in the development and maintenance of GI symptoms were explored by looking at the microbiota-gut-brain axis involvement. Moreover, we sought to examine the effects of lyso-Gb3 on colonic contractility and the intestinal epithelium and the enteric nervous system, which together play important roles in regulating intestinal ion transport and fluid and electrolyte homeostasis. Fabry mice revealed visceral hypersensitivity and a diarrhea-like phenotype accompanied by anxious-like behavior and reduced locomotor activity. They reported also an imbalance of SCFAs and an early compositional and functional dysbiosis of the gut microbiota, which partly persisted with advancing age. Moreover, overexpression of TRPV1 was found in affected mice, and partial alteration of TRPV4 and TRPA1 as well, identifying them as possible therapeutic targets. The Ussing chamber results after treatment with lyso-Gb3 showed an increase in Isc (likely mediated by HCO3- ions movement) which affects neuron-mediated secretion, especially capsaicin- and partly veratridine-mediated. This first characterization of gut-brain axis dysfunction in FD mouse provides functional validation of the model, suggesting new targets and possible therapeutic approaches. Furthermore, lyso-Gb3 is confirmed to be not only a marker for the diagnosis and follow-up of FD but also a possible player in the alteration of the FD colonic ion transport process.